Accel Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Accel Wealth Management's PFE Position: Q2 2026 in Review
Accel Wealth Management reduced its Pfizer (PFE) stake by 0.59% in Q2 2026, selling an estimated $1.6K and leaving 10,265 shares worth $247K. The position accounts for 0.06% of the portfolio, ranked #253.
Accel Wealth Management first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $337K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Accel Wealth Management held 10,265 shares of Pfizer worth $247K as of Q2 2026.
- Accel Wealth Management sold 61 Pfizer shares in Q2 2026, an estimated $1.6K.
- Pfizer made up 0.06% of Accel Wealth Management's portfolio in Q2 2026, its #253 holding.
- Accel Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- Accel Wealth Management's Pfizer position peaked at $337K in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.